Lazard Asset Management
FMS icon

Lazard Asset Management’s Fresenius Medical Care FMS Stock Holding History

Lazard Asset Management’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-325
Closed -$8K – 2371
2025
Q1 		$8K Sell
325
-11
-3% -$262 ﹤0.01% 2159
2024
Q4 		$7K Sell
336
-82
-20% -$1.78K ﹤0.01% 2115
2024
Q3 		$8K Buy
418
+157
+60% +$3.09K ﹤0.01% 2036
2024
Q2 		$4K Buy
+261
New +$5.32K ﹤0.01% 2068
2024
Q1 		– Sell
-357
Closed -$7K – 2156
2023
Q4 		$7K Sell
357
-314
-47% -$6.03K ﹤0.01% 2107
2023
Q3 		$14K Buy
+671
New +$16.3K ﹤0.01% 2131
2018
Q2 		– Sell
-21
Closed -$1K – 1060
2018
Q1 		$1K Buy
+21
New +$1.12K ﹤0.01% 1026
2015
Q1 		– Sell
-157
Closed -$5K – 1152
2014
Q4 		$5K Buy
+157
New +$5.66K ﹤0.01% 1102

Other funds holding FMS

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lazard Asset Management's FMS Position: Q2 2025 in Review

Lazard Asset Management sold out of Fresenius Medical Care (FMS) in Q2 2025, closing a stake of 325 shares — an estimated $8K sold.

Lazard Asset Management first reported a position in FMS in Q4 2014 and held it in 8 quarters. The position peaked at $14K in Q3 2023. 207 funds tracked by Wall St. Rank hold FMS as of Q2 2025.

  • Lazard Asset Management reported no remaining Fresenius Medical Care position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 325 Fresenius Medical Care shares in Q2 2025, an estimated $8K.
  • Lazard Asset Management first reported a position in Fresenius Medical Care in Q4 2014 and held it in 8 quarters.
  • Lazard Asset Management's Fresenius Medical Care position peaked at $14K in Q3 2023.
  • 207 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.